Skip Navigation

JNCI Journal of the National Cancer Institute 2002 94(22):1721-1722; doi:10.1093/jnci/94.22.1721
© 2002 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Love, R. R.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Love, R. R.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 94, No. 22, 1721-1722, November 20, 2002
© 2002 Oxford University Press

CORRESPONDENCE

RESPONSE Re: Mastectomy and Oophorectomy by Menstrual Cycle Phase in Women With Operable Breast Cancer

Richard R. Love

Correspondence to: Richard R. Love, M.D., M.S., Medical Oncology Section, Department of Medicine, University of Wisconsin School of Medicine, 610 Walnut St., 256 WARF, Madison, WI 53705 (e-mail: rrlove@facstaff.wisc.edu).

The first 10% of the full text of this article appears below.

Like our reported analysis (1), the analysis reported by Milella et al. is exploratory. The similar levels of benefit seen in the estrogen receptor-positive and estrogen receptor-negative luteal phase operated subsets [see Fig. 4 in (2)] are not inconsistent with the overall results [see . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?